Last year, Boeing shares took a hit due to quality control issues and a machinists' strike, dropping by 32%. However, Tim Seymour from Seymour Asset Management believes that investors should not give up on the stock just yet.
With a renewed focus on generating cash and improving operational efficiency, Boeing is poised to bounce back and regain investor confidence. Seymour's optimistic outlook on Boeing underscores the notion that the company has the potential to turn the corner and thrive in the evolving aerospace industry landscape.
Boeing's Recovery and Future Outlook
Despite hitting a closing low in November 2024, Boeing has staged a remarkable comeback, with a 34% increase in its stock value. Seymour is optimistic about the aerospace giant, stating that the company has addressed its cash burn and is on track to become free-cash-flow positive by 2026.
CVS Health Showing Strong Performance
Another stock in focus is CVS Health, which had a challenging 2024, ending the year with a 43% decline. However, the company has seen a 47% increase in its shares this year, driven by a strong fourth-quarter earnings report. Seymour praised the new CEO, David Joyner, for his efforts in turning around the business.
Intel: A Stock to Avoid
Conversely, Seymour advised against investing in Intel, which saw a 60% drop in its shares last year. Despite a recent increase following government statements on defending AI and chip technologies, Seymour expressed disappointment in the company's direction and recommended avoiding the stock.
